mBio
(Feb 2021)
Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis
Wern Hann Ng,
Thomas Tipih,
Nigel A. Makoah,
Jan-G Vermeulen,
Dominique Goedhals,
Joseph B. Sempa,
Felicity J. Burt,
Adam Taylor,
Suresh Mahalingam
Affiliations
Wern Hann Ng
ORCiD Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Southport, QLD, Australia
Thomas Tipih
ORCiD Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
Nigel A. Makoah
ORCiD Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
Jan-G Vermeulen
ORCiD Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
Dominique Goedhals
ORCiD Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
Joseph B. Sempa
ORCiD Department of Biostatistics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
Felicity J. Burt
ORCiD Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
Adam Taylor
ORCiD Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Southport, QLD, Australia
Suresh Mahalingam
ORCiD Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Southport, QLD, Australia
DOI
https://doi.org/10.1128/mBio.03647-20
Journal volume & issue
Vol. 12,
no. 1
Abstract
Read online
COVID-19 has plagued the world since it was first identified in December 2019. Previous systematic reviews and meta-analysis were limited by various factors such as the usage of non-peer reviewed data and were also limited by the lack of clinical data on a global scale.
WeChat QR code
Close
